Development of 2-(5,6,7-Trifluoro-1H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer

2021 ◽  
Author(s):  
Eric Leblanc ◽  
Fuqiang Ban ◽  
Ayse Derya Cavga ◽  
Sam Lawn ◽  
Chia-Chi Flora Huang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Castration Resistant Prostate Cancer ◽  
Receptor Targeting ◽  
Castration Resistant ◽  
Binding Function ◽  
Human Androgen Receptor

Outcomes of crossover between androgen receptor targeting drugs in the castration resistant prostate cancer registry (CAPRI)

2018 ◽  
Vol 17 (2) ◽  
pp. e878-e879
Author(s):  
M. Kuppen ◽  
H. Westgeest ◽  
F. Van Den Eertwegh ◽  
J. Van Moorselaar ◽  
R. De Wit ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Registry ◽  
Castration Resistant Prostate Cancer ◽  
Receptor Targeting ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document